This invention relates to anti-P-selectin antibodies and, in particular, to anti-P-selectin antibodies and variants thereof that contain an Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from critical limb ischemia or peripheral arterial occlusive disease (CLI/PAOD).

 
Web www.patentalert.com

< Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same

> Methods and compositions for inducing autoimmunity in the treatment of cancers

> Coatings for implantable medical devices

~ 00534